{
 "PrintNo":"A4585","Version":"A","Session":2021,"Chamber":"ASSEMBLY","BillType":"Assembly",
 "Published":"2021-02-04T15:23:51.388888Z","Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2022-01-05","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2021-02-04","Chamber":"ASSEMBLY"},
  {"Text":"AMEND AND RECOMMIT TO HEALTH","Date":"2021-02-19","Chamber":"ASSEMBLY"},
  {"Text":"PRINT NUMBER 4585A","Date":"2021-02-19","Chamber":"ASSEMBLY","Version":"A"},
  {"Text":"REFERRED TO HEALTH","Date":"2022-01-05","Chamber":"ASSEMBLY","Version":"A"}
 ],
 "Sponsors":[
  {"ID":1470,"Name":"Jenifer Rajkumar","Short":"RAJKUMAR"},{"ID":474,"Name":"Charles Lavine","Short":"LAVINE"},
  {"ID":519,"Name":"Deborah Glick","Short":"GLICK"},
  {"ID":898,"Name":"Rodneyse Bichotte Hermelyn","Short":"BICHOTTE HERMELYN"},
  {"ID":484,"Name":"David Weprin","Short":"WEPRIN"},{"ID":491,"Name":"Catherine Nolan","Short":"NOLAN"},
  {"ID":1243,"Name":"Simcha Eichenstein","Short":"EICHENSTEIN"},{"ID":488,"Name":"Andrew Hevesi","Short":"HEVESI"},
  {"ID":1477,"Name":"Amanda Septimo","Short":"SEPTIMO"},{"ID":1459,"Name":"Khaleel Anderson","Short":"ANDERSON"},
  {"ID":610,"Name":"Edward Braunstein","Short":"BRAUNSTEIN"},{"ID":621,"Name":"Sandy Galef","Short":"GALEF"},
  {"ID":1471,"Name":"Emily Gallagher","Short":"GALLAGHER"},{"ID":457,"Name":"Vivian Cook","Short":"COOK"},
  {"ID":498,"Name":"Steven Cymbrowitz","Short":"CYMBROWITZ"},{"ID":906,"Name":"Rebecca Seawright","Short":"SEAWRIGHT"},
  {"ID":1474,"Name":"Phara Souffrant Forrest","Short":"FORREST"},
  {"ID":570,"Name":"William Magnarelli","Short":"MAGNARELLI"},{"ID":900,"Name":"Erik Dilan","Short":"DILAN"},
  {"ID":622,"Name":"Thomas Abinanti","Short":"ABINANTI"},{"ID":1258,"Name":"Nader Sayegh","Short":"SAYEGH"}
 ],
 "Title":"Relates to the administration of the monoclonal antibody treatment for certain patients suffering from COVID-19",
 "Summary":"Requires health care providers to inform eligible patients who have tested positive and who are at high risk of severe illness from COVID-19 of the option for monoclonal antibody treatment and to administer such therapy or assist the patient in obtaining the treatment from another provider.",
 "LawSection":"Public Health Law","LawCode":"Ren ยง2182 to be ยง2183, add ยง2182, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to administration of the monoclonal antibody treatment for high risk patients suffering from COVID-19"
}